Mary E. Smith - Publications

University of California, San Diego, La Jolla, CA 

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Witthoft N, Nguyen ML, Golarai G, LaRocque KF, Liberman A, Smith ME, Grill-Spector K. Where is human V4? Predicting the location of hV4 and VO1 from cortical folding. Cerebral Cortex (New York, N.Y. : 1991). 24: 2401-8. PMID 23592823 DOI: 10.1093/cercor/bht092  0.8
2014 Troiani V, Stigliani A, Smith ME, Epstein RA. Multiple object properties drive scene-selective regions. Cerebral Cortex (New York, N.Y. : 1991). 24: 883-97. PMID 23211209 DOI: 10.1093/cercor/bhs364  0.8
2014 Farah MJ, Smith ME, Ilieva I, Hamilton RH. Cognitive enhancement Wiley Interdisciplinary Reviews: Cognitive Science. 5: 95-103. DOI: 10.1002/wcs.1250  0.8
2013 LaRocque KF, Smith ME, Carr VA, Witthoft N, Grill-Spector K, Wagner AD. Global similarity and pattern separation in the human medial temporal lobe predict subsequent memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 5466-74. PMID 23536062 DOI: 10.1523/JNEUROSCI.4293-12.2013  0.8
2012 Desmarais C, Roeber BJ, Smith ME, Pollak SD. Sentence comprehension in postinstitutionalized school-age children. Journal of Speech, Language, and Hearing Research : Jslhr. 55: 45-54. PMID 22199198 DOI: 10.1044/1092-4388(2011/10-0246)  0.8
2011 Chokephaibulkit K, Cressey TR, Capparelli E, Sirisanthana V, Muresan P, Hongsiriwon S, Ngampiyaskul C, Limwongse C, Wittawatmongkol O, Aurpibul L, Kabat B, Toye M, Smith ME, Eksaengsri A, McIntosh K, et al. Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children Antiviral Therapy. 16: 1287-1295. PMID 22155910 DOI: 10.3851/IMP1931  0.8
2011 Farah MJ, Smith ME. Discussing smart pills versus endorsing smart pills: reply to Swanson, Wigal, and Volkow (2011) and Elliott and Elliott (2011). Psychological Bulletin. 137: 751-2. PMID 21859177 DOI: 10.1037/a0024846  0.8
2011 Smith ME, Farah MJ. Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin. 137: 717-41. PMID 21859174 DOI: 10.1037/a0023825  0.8
2010 Vanprapar N, Cressey TR, Chokephaibulkit K, Muresan P, Plipat N, Sirisanthana V, Prasitsuebsai W, Hongsiriwan S, Chotpitayasunondh T, Eksaengsri A, Toye M, Smith ME, McIntosh K, Capparelli E, Yogev R, et al. A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand. The Pediatric Infectious Disease Journal. 29: 940-4. PMID 20453709 DOI: 10.1097/INF.0b013e3181e2189d  0.8
2009 Le A, Hoehn ME, Smith ME, Spentzas T, Schlappy D, Pershad J. Bedside sonographic measurement of optic nerve sheath diameter as a predictor of increased intracranial pressure in children. Annals of Emergency Medicine. 53: 785-91. PMID 19167786 DOI: 10.1016/j.annemergmed.2008.11.025  0.8
2009 Farah MJ, Smith ME, Gawuga C, Lindsell D, Foster D. Brain imaging and brain privacy: a realistic concern? Journal of Cognitive Neuroscience. 21: 119-27. PMID 18476762 DOI: 10.1162/jocn.2009.21010  0.8
2009 Farah MJ, Haimm C, Sankoorikal G, Smith ME, Chatterjee A. When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study (Psychopharmacology (2009) 202, (541-547) DOI: 10.1007/s00213-008-1369-3) Psychopharmacology. 203: 651. DOI: 10.1007/s00213-009-1507-6  0.8
2008 Read JS, Best BM, Stek AM, Hu C, Capparelli EV, Holland DT, Burchett SK, Smith ME, Sheeran EC, Shearer WT, Febo I, Mirochnick M. Pharmacokinetics of new 625mg nelfinavir formulation during pregnancy and postpartum Hiv Medicine. 9: 875-882. PMID 18795962 DOI: 10.1111/j.1468-1293.2008.00640.x  0.8
2008 Salazar JC, Cahn P, Yogev R, Negra MD, Castelli-Gattinara G, Fortuny C, Flynn PM, Giaquinto C, Ruan PK, Smith ME, Mikl J, Jelaska A. Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents. Aids (London, England). 22: 1789-98. PMID 18753862 DOI: 10.1097/QAD.0b013e32830c481b  0.8
2008 Robbins BL, Capparelli EV, Chadwick EG, Yogev R, Serchuck L, Worrell C, Smith ME, Alvero C, Fenton T, Heckman B, Pelton SI, Aldrovandi G, Borkowsky W, Rodman J, Havens PL, et al. Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors. Antimicrobial Agents and Chemotherapy. 52: 3276-83. PMID 18625762 DOI: 10.1128/AAC.00224-08  0.8
2008 Appleby L, Luchins DJ, Freels S, Smith ME, Wasmer D. The impact of immigration on psychiatric hospitalization in Illinois from 1993 to 2003. Psychiatric Services (Washington, D.C.). 59: 648-54. PMID 18511585 DOI: 10.1176/  0.8
2007 McKinney RE, Rodman J, Hu C, Britto P, Hughes M, Smith ME, Serchuck LK, Kraimer J, Ortiz AA, Flynn P, Yogev R, Spector S, Draper L, Tran P, Scites M, et al. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics. 120: e416-23. PMID 17646352 DOI: 10.1542/peds.2006-0925  0.8
2007 Fletcher CV, DeVille JG, Samson PM, Moye JH, Church JA, Spiegel HM, Palumbo P, Fenton T, Smith ME, Graham B, Kraimer JM, Shearer WT. Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children. The Journal of Allergy and Clinical Immunology. 119: 747-50. PMID 17336619 DOI: 10.1016/j.jaci.2006.10.045  0.8
2006 Shearer WT, DeVille JG, Samson PM, Moye JH, Fletcher CV, Church JA, Spiegel HM, Palumbo P, Fenton T, Smith ME, Graham B, Kraimer JM, Olson WC. Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). The Journal of Allergy and Clinical Immunology. 118: 518-21. PMID 16890780 DOI: 10.1016/j.jaci.2006.03.028  0.8
2006 Nozyce ML, Lee SS, Wiznia A, Nachman S, Mofenson LM, Smith ME, Yogev R, McIntosh K, Stanley K, Pelton S. A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics. 117: 763-70. PMID 16510656 DOI: 10.1542/peds.2005-0451  0.8
2004 Wade NA, Unadkat JD, Huang S, Shapiro DE, Mathias A, Yasin S, Ciupak G, Watts DH, Delke I, Rathore M, Hitti J, Frenkel L, Samelson R, Smith ME, Mofenson L, et al. Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332. The Journal of Infectious Diseases. 190: 2167-74. PMID 15551216 DOI: 10.1086/425903  0.8
2002 Yogev R, Lee S, Wiznia A, Nachman S, Stanley K, Pelton S, Mofenson L, Fiscus S, Jimenez E, Rathore MH, Smith ME, Song LY, Mcintosh K. Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection Pediatric Infectious Disease Journal. 21: 119-125. PMID 11840078 DOI: 10.1097/00006454-200202000-00007  0.8
2001 Schifitto G, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra CM, Rubin M, Cohen BA, Tucker T, Koralnik IJ, Katzenstein D, Haidich B, Smith ME, Shriver S, et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology. 57: 1313-6. PMID 11591856  0.8
2000 Lovett-Racke AE, Smith ME, Arredondo LR, Bittner PS, Ratts RB, Shive CL, Forsthuber TG, Racke MK. Developmentally regulated gene expression of Th2 cytokines in the brain Brain Research. 870: 27-35. PMID 10869498 DOI: 10.1016/S0006-8993(00)02398-2  0.8
2000 McArthur JC, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra C, Rubin M, Cohen BA, Tucker T, Navia BA, Schifitto G, Katzenstein D, Rask C, Zaborski L, ... Smith ME, et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology. 54: 1080-8. PMID 10720278  0.8
2000 Nachman SA, Stanley K, Yogev R, Pelton S, Wiznia A, Lee S, Mofenson L, Fiscus S, Rathore M, Jimenez E, Borkowsky W, Pitt J, Smith ME, Wells B, McIntosh K. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team. Jama. 283: 492-8. PMID 10659875  0.8
1999 Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. The American Journal of Pathology. 155: 1147-61. PMID 10514398 DOI: 10.1016/S0002-9440(10)65218-2  0.8
1999 Gobbini MI, Smith ME, Richert ND, Frank JA, McFarland HF. Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 99: 142-9. PMID 10496187 DOI: 10.1016/S0165-5728(99)00039-9  0.8
1996 Clawson J, Martin R, Lloyd B, Smith M, Cady G. The EMD (emergency medical dispatcher) as a medical professional Jems : a Journal of Emergency Medical Services. 21: 68-71, 75-77. PMID 10157073  0.8
1996 Smith ME, Eller NL. Gender influences eae both before and after sexual maturation Faseb Journal. 10: A1353.  0.8
1995 Stone LA, Smith ME, Albert PS, Bash CN, Maloni H, Frank JA, McFarland HF. Blood-brain barrier disruption on contrast-enhanced mri in patients with mild relapsing-remitting multiple sclerosis: Relationship to course, gender, and age Neurology. 45: 1122-1126. PMID 7783875  0.8
1995 Stone LA, Frank JA, Albert PS, Bash C, Smith ME, Maloni H, McFarland HF. The effect of interferon-β on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis Annals of Neurology. 37: 611-619. PMID 7755356  0.8
1995 Stone LA, Albert PS, Smith ME, DeCarli C, Armstrong MR, McFarlin DE, Frank JA, McFarland HF. Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology. 45: 1808-14. PMID 7477973  0.8
1994 Albert PS, McFarland HF, Smith ME, Frank JA. Time series for modelling counts from a relapsing-remitting disease: Application to modelling disease activity in multiple sclerosis Statistics in Medicine. 13: 453-466. PMID 8023028  0.8
1994 Frank JA, Stone LA, Smith ME, Albert PS, Maloni H, McFarland HF. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: Implications for treatment trials Annals of Neurology. 36: S86-S90. PMID 8017894 DOI: 10.1002/ana.410360719  0.8
1994 Whitaker JN, Williams PH, Layton BA, McFarland HF, Stone LA, Smith ME, David Kachelhofer R, Bradley EL, Burgard S, Zhao G, Paty DW. Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis Annals of Neurology. 35: 577-585. PMID 7513981 DOI: 10.1002/ana.410350511  0.8
1993 Smith ME, Katz DA, Harris JO, Frank JA, Kufta CV, McFarlin DE. Systemic histiocytosis presenting as multiple sclerosis Annals of Neurology. 33: 549-554. PMID 8498832  0.8
1993 Smith ME, Stone LA, Albert PS, Frank JA, Martin R, Armstrong M, Maloni H, McFarlin DE, McFarland HF. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine - Enhancing magnetic resonance imaging lesions Annals of Neurology. 33: 480-489. PMID 8498825  0.8
1993 Smith ME, Loftus-Rueckheim P. Service utilization patterns as determinants of capitation rates Hospital and Community Psychiatry. 44: 49-53. PMID 8436360  0.8
1993 Posse S, Schuknecht B, Smith ME, van Zijl PC, Herschkowitz N, Moonen CT. Short echo time proton MR spectroscopic imaging. Journal of Computer Assisted Tomography. 17: 1-14. PMID 8380426  0.8
1993 Smith ME, McFarlin DE, Dhib-Jalbut S. Differential effect of interleukin-1β on Ia expression in astrocytes and microglia Journal of Neuroimmunology. 46: 97-104. PMID 8360333 DOI: 10.1016/0165-5728(93)90238-T  0.8
1992 McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, Patronas N, Maloni H, McFarlin DE. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis Annals of Neurology. 32: 758-766. PMID 1471866  0.8
Show low-probability matches.